Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
No matches found
Show only United States results
Show subsections
IND
USA
MARKETS
SECTOR : PHARMA & BIOTECH
INDUSTRY : MAJOR PHARMACEUTICALS
NEUROCRINE BIOSCIENCES, INC.
Neurocrine Biosciences, Inc.
XNAS: NBIX
Turnaround Potential
Download real time
139.60
0.66
(
0.48
%)
65.74% Gain from 52W Low
503.7K
XNAS Volume
XNAS
29 Aug, 2025 5:30 PM (EDT)
Watchlist
Portfolio
Alert
Share
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
My Notes
Board Meeting
The next board meeting for Neurocrine Biosciences, Inc. is on 10 Sep 2025 for the purpose of Baird 2025 Global Healthcare Conference
See details
Overview
Buy Sell Zone
Financials
Forecaster
Competitors/Peers
Quarterly Results
Annual Results
Balance Sheet
Financial Ratios
Cash Flow
Technicals
Share Price History
Ownership
Insider Deals
Corporate Actions
All
Dividend
Split
Board Meetings
About
Neurocrine Biosciences, Inc. quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents